Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination

June 27, 2024

https://www.globenewswire.com/news-release/2024/06/27/2905429/0/en/Denali-Capital-Acquisition-Corp-and-Longevity-Biomedical-Inc-Mutually-Agreed-to-Terminate-the-Business-Combination.html

NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Denali Capital Acquisition Corp. (NASDAQ:DECA) (“Denali” or the “Company”) announced today that Denali and Longevity Biomedical, Inc. have mutually agreed to terminate their previously announced business combination agreement (the “Business Combination Agreement”).  The Company and its sponsor intend to seek alternative ways to consummate an initial business combination.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.